Related Experiment Video

Updated: Jun 29, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Therapeutic potential of stem cells in elderly patients with cardiovascular disease

M Brehm1, B Stanske, B E Strauer

  • 1Department of Cardiology, Pneumology and Vascular Medicine, Heinrich-Heine University, Düsseldorf, Germany. brehm@med.uni-duesseldorf.de

Experimental Gerontology
|October 11, 2008
PubMed

Insights

Elderly patients with chronic heart failure may benefit from autologous bone marrow-derived mononuclear cell therapy. This novel approach explores stem cell potential for tissue regeneration in myocardial ischemia.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Geriatrics

Background:

  • Improved treatments for acute myocardial infarction and chronic ischemia have increased the population of heart failure patients.
  • Current therapies enhance quality of life and lifespan but many elderly patients remain symptomatic.
  • Autologous bone marrow-derived mononuclear cells offer a novel therapeutic option for tissue repopulation.

Purpose of the Study:

  • To review the current understanding of stem cell therapy.
  • To discuss early clinical experiences with stem cell application.
  • To relate stem cell therapy to elderly patients with myocardial ischemia.

Main Methods:

  • Review of current literature on stem cell therapy for cardiovascular conditions.
  • Analysis of early clinical data regarding autologous bone marrow-derived mononuclear cells.
  • Focus on application in elderly patients with symptomatic myocardial ischemia.

Main Results:

  • Stem cell therapy is an emerging option for tissue regeneration in heart failure.
  • Autologous bone marrow-derived mononuclear cells show potential for myocardial repair.
  • Further research is needed to establish efficacy and safety in elderly populations.

Conclusions:

  • Stem cell therapy, specifically using autologous bone marrow-derived mononuclear cells, presents a promising avenue for treating elderly patients with chronic heart failure and myocardial ischemia.
  • While current treatments have improved outcomes, a significant unmet need exists for symptomatic patients, particularly the elderly.
  • This review highlights the potential of regenerative medicine to address tissue loss and improve clinical results in this vulnerable patient group.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...